Stockreport

Protagonist Therapeutics Should Be Avoided After Phase 2b Flop [Seeking Alpha]

Protagonist Therapeutics, Inc.  (PTGX) 
Last protagonist therapeutics, inc. earnings: 3/10 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.protagonist-inc.com
PDF Protagonist Therapeutics Should Be Avoided After Phase 2b FlopSummaryProtagonist Therapeutics fails phase 2b PROPEL study treating patients with ulcerative colitis using [Read more]